Acrivon Therapeutics, Inc.
ACRV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001781174
In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Acrivon Therapeutics, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +22 vs. Q4 2022
- Shares held
- 15.2M
- +534.7K (+3.6%) vs. Q4 2022
- Total value
- $191.1M
- +$24.0M (+14.3%) vs. Q4 2022
- New holders
- 25
- 6 more added
- Sold out
- 3
- 4 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 46 | $38.1M |
| Q1 2026 | 44 | $22.6M |
| Q4 2025 | 48 | $44.9M |
| Q3 2025 | 48 | $31.7M |
| Q2 2025 | 53 | $21.2M |
| Q1 2025 | 63 | $45.7M |
| Q4 2024 | 63 | $140.0M |
| Q3 2024 | 55 | $160.8M |
| Q2 2024 | 55 | $136.1M |
| Q1 2024 | 48 | $109.0M |
| Q4 2023 | 42 | $74.5M |
| Q3 2023 | 43 | $144.3M |
| Q2 2023 | 40 | $196.0M |
| Q1 2023 | 39 | $191.1M |
| Q4 2022 | 18 | $170.4M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 122 | $1.55K | 0.00% | +122 | New |
| Citigroup Inc | 202 | $2.56K | 0.00% | +202 | New |
| Metropolitan Life Insurance Co | 523 | $6.64K | 0.00% | +523 | New |
| Royal Bank of Canada | 665 | $8.00K | 0.00% | +665 | New |
| Ameritas Investment Partners, Inc. | 695 | $8.82K | 0.00% | +695 | New |
| Legal & General Group Plc | 924 | $11.7K | 0.00% | +924 | New |
| Tower Research Capital LLC (TRC) | 1,092 | $14.0K | 0.00% | +933+586.8% | Added |
| Amalgamated Bank | 1,130 | $14.0K | 0.00% | +1,130 | New |
| Wells Fargo & Company | 1,588 | $20.2K | 0.00% | +1,588 | New |
| STRS Ohio | 1,800 | $22.0K | 0.00% | +1,800 | New |
| New York State Common Retirement Fund | 2,206 | $28.0K | 0.00% | +2,206 | New |
| California State Teachers Retirement System | 3,218 | $40.8K | 0.00% | +3,218 | New |
| American International Group, Inc. | 4,178 | $53.0K | 0.00% | +4,178 | New |
| MetLife Investment Management | 5,081 | $64.5K | 0.00% | +5,081 | New |
| Deutsche Bank AG | 5,369 | $68.1K | 0.00% | +5,369 | New |
| UBS Group AG | 5,396 | $68.5K | 0.00% | +648+13.6% | Added |
| Morgan Stanley | 5,624 | $71.4K | 0.00% | +4,755+547.2% | Added |
| Bank of America Corp | 5,856 | $74.3K | 0.00% | +5,856 | New |
| JPMorgan Chase & Co | 6,630 | $84.0K | 0.00% | +6,630 | New |
| Goldman Sachs Group Inc | 13,718 | $174.1K | 0.00% | −25,082−64.6% | Reduced |
| Barclays PLC | 16,983 | $215.5K | 0.00% | +12,841+310.0% | Added |
| Bank of New York Mellon Corp | 22,837 | $289.8K | 0.00% | +22,837 | New |
| Susquehanna International Group, LLP | 32,262 | $409.4K | 0.00% | +32,262 | New |
| DAFNA Capital Management LLC | 51,148 | $649.1K | 0.19% | +35,500+226.9% | Added |
| Charles Schwab Investment Management Inc | 58,209 | $738.7K | 0.00% | +58,209 | New |
| D. E. Shaw & Co., Inc. | 61,896 | $785.5K | 0.00% | +61,896 | New |
| Northern Trust Corp | 69,751 | $885.1K | 0.00% | +69,751 | New |
| State Street Corp | 85,339 | $1.08M | 0.00% | +85,339 | New |
| Geode Capital Management, LLC | 175,404 | $2.23M | 0.00% | +175,404 | New |
| NEA Management Company, LLC | 481,677 | $4.89M | 0.34% | 00.0% | Unchanged |
| Vanguard Group Inc | 409,215 | $5.19M | 0.00% | +409,215 | New |
| BlackRock Inc. | 474,227 | $6.02M | 0.00% | +474,227 | New |
| Marshall Wace, LLP | 597,469 | $7.58M | 0.02% | −625,783−51.2% | Reduced |
| Federated Hermes, Inc. | 613,625 | $7.79M | 0.02% | −209,675−25.5% | Reduced |
| Wellington Management Group LLP | 888,130 | $11.1M | 0.00% | −12,019−1.3% | Reduced |
| Citadel Advisors LLC | 1,641,022 | $20.1M | 0.02% | +6,918+0.4% | Added |
| Sands Capital Ventures, LLC | 1,652,605 | $21.0M | 5.18% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 3,007,858 | $38.2M | 1.13% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 4,810,508 | $61.0M | 1.38% | 00.0% | Unchanged |
| Bank of Montreal | 0 | $0 | 0.00% | −42,444−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,534−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −19,639−100.0% | Sold out |
| HealthCor Management, L.P. | – | – | – | – | Not filed |